A detailed history of Voisard Asset Management Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 1,355 shares of BMRN stock, worth $88,969. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,355
Previous 1,150 17.83%
Holding current value
$88,969
Previous $94.7 Million 0.59%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$69.02 - $93.84 $14,149 - $19,237
205 Added 17.83%
1,355 $95.2 Million
Q1 2024

Apr 16, 2024

BUY
$83.81 - $99.0 $10,476 - $12,375
125 Added 12.2%
1,150 $100 Million
Q4 2023

Feb 20, 2024

BUY
$76.22 - $98.51 $78,125 - $100,972
1,025 New
1,025 $98.8 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Voisard Asset Management Group, Inc. Portfolio

Follow Voisard Asset Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voisard Asset Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voisard Asset Management Group, Inc. with notifications on news.